<DOC>
	<DOCNO>NCT01454050</DOCNO>
	<brief_summary>The objective study prove safety efficacy Lumax 740 ICD family . Primarily , newly implement RV/LV Capture Control algorithm evaluate , automatically measure RV/LV threshold subsequently adjust pace output .</brief_summary>
	<brief_title>Lumax 740 Master Study</brief_title>
	<detailed_description />
	<criteria>Standard indication single , dual , triple chamber ICD . Legal capacity ability consent Signed patient inform consent In addition HFT device : Bipolar LVlead min . distance 15 mm tip ring True bipolar RV lead Standard contraindication single , dual , triple chamber ICD . Age &lt; 18 year Pregnant breastfeed woman Cardiac surgery plan within next 6 month Life expectancy le 6 month Participating clinical study investigational cardiac drug device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>ICD therapy</keyword>
	<keyword>RV/LV Capture Control</keyword>
	<keyword>Safety Efficacy</keyword>
</DOC>